Although AD patients tend to be physiologically overall insulin resistant, evidence also suggests that the level of insulin/insulin signaling is unchanged or increased in AD brains12, and downstream activity like AKT (also known as PKB, protein kinase B) is upregulated13,14. This evidence concerns the gene INS and Alzheimer disease.